Cargando…
Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of Osteoarthritis
Osteoarthritis (OA) is a slowly progressive joint disease typically seen in middle-age to elderly people. At present, there is no ideal agent to treat OA. Chenodeoxycholic acid (CDCA) was a principal active constituent from animal bile. However, the therapeutic effect of CDCA on OA severity was larg...
Autores principales: | Yan, Zhao-wei, Dong, Ji, Qin, Chen-hao, Zhao, Chun-yang, Miao, Li-yan, He, Chun-yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619964/ https://www.ncbi.nlm.nih.gov/pubmed/26538834 http://dx.doi.org/10.1155/2015/780149 |
Ejemplares similares
-
Synergistic Inhibition of MRSA by Chenodeoxycholic Acid and Carbapenem Antibiotics
por: Cui, Kaiyu, et al.
Publicado: (2022) -
Chenodeoxycholic Acid-Amikacin Combination Enhances Eradication of Staphylococcus aureus
por: Cui, Kaiyu, et al.
Publicado: (2023) -
Efficacy of Chenodeoxycholic Acid and Ursodeoxycholic Acid Treatments for Refractory Functional Dyspepsia
por: Jang, Sung Ill, et al.
Publicado: (2022) -
Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis
por: Gong, Zizhen, et al.
Publicado: (2016) -
Chenodeoxycholic Acid Derivative HS-1200 Inhibits Hepatocarcinogenesis and Improves Liver Function in Diethylnitrosamine-Exposed Rats by Downregulating MTH1
por: Xu, Miao, et al.
Publicado: (2017)